AIDS | Infectious Disease Conferences | HIV | STD | STI Events | Meetings | Europe | USA | 2017| Middle East

Theme: Creating new wind to prevent HIV/AIDS, STDs & STIs

STD-HIV/AIDS 2017

ConferenceProgram

Renowned Speakers

Marc H.V. Van Regenmortel
Director
France

Kevin Galalae
Center of Global Consciousness
Canada

Mandy J. Hill
Assistant Research Director
USA

Gabriela Gore-Gorszewska
Jagiellonian University
Poland

David L. Massey
HIV/AIDS Advocate Atlanta Metro
USA

Debbie Y Mohammed
Saint Michaelâ€™s Medical Center
USA

Saint Michaelâ€™s Medical Center
Federal University of Rio de Janeiro
Brazil

P.S.Shantanu Rao
University of Tennessee Health Science Center
USA

STD-HIV/AIDS 2017

Track 1: Types of HIV/AIDS, STDs & STIs

Sexually transmitted diseases (STDs) remain infections that you can acquire thru having sex or skin-to-skin contact among genitals with somebody who has STD and these are too every so often called sexually transmitted diseases or Sexually Transmitted Infections (STIs). Whatever you call them, they can cause severe health difficulties. And they happen a lot to young persons: Around half of all new infections occur to people ages 15 to 24. There are nearly 25 STDs caused by numerous unlike bacteria and viruses. Each STD has its individual warning sign, but certain have alike symptoms. Dealing of viral infections such as HIV involves patient care and ethical support including antiretroviral treatment. Bacterial infections can be cured by administering antibiotics to the patients. Yeast infections can be principally treated by sterilisation methods.

The Centers for Disease Control and Prevention assessments that in 2007, there were around 24,000 HIV-infected youth among 13 and 24 years of age in the US. Presently, HIV infection is the seventh foremost reason of death in this age group. Throughout 2001–2004, in the 33 states with trusted name-based HIV reporting, there were 17,824 persons 13–24 years of age with an analysis of HIV/AIDS, of whom 62% were males.

List of HIV Organizations: Global HIV/AIDS Organizations, USA ; National AIDS Control Organization, India; The Joint United Nations Programme on HIV/AIDS, Switzerland; South African AIDS Support Organisation, South Africa; China AIDS Fund, China; Thai national AIDS foundation, Thailand; AVERT, Russia; National AIDS Trust, UK; AIDS Foundation of South Africa, South Africa; Southern Africa HIV and AIDS Regional Exchange, Zimbabwe; New Zealand AIDS Foundation, New Zealand; AIDS United, USA; Action for AIDS Singapore, Singapore; The Networking HIV/AIDS Community of South Africa, South Africa; The Legatum Foundation, Ukraine; National Agency for the Control of AIDS, NIGERIA; Australian Federation of AIDS Organisations, Australia.

Related Top AIDS Conferences : 5^th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017; Non-Communicable Diseases and Therapies, November 16- 17, 2017 Las Vegas, USA; Vancouver, Canada; 4th World Congress on Infection Prevention and Control, November 13-15, 2017 Las Vegas, USA; 2017 American Conference for the Treatment of HIV April 20-22 2017, Dallas, USA; 16th European AIDS Conference October 25-28 2017, Milan, Italy; 7th International Workshop on HIV & Women, February 11-12 2017,Seattle, WA; 13th International Workshop on Co-Infection – HIV & Hepatitis, May 24-26 2017, Lisbon, Portugal.

Track 2: Bacterial, Viral and Parasitic STDs & STIs

A Sexually Transmitted Infection (STI) is an infection that is delivered on from one person to another thru sexual activity. There are numerous unlike categories of STIs that can be distributed on during oral sex, vaginal sex or anal sex. Certain can even be passed on by skin-to-skin genital interaction. It is significant to treat STIs as soon as possible and not to spread them. Numerous can simply be treated, but if an STI is left untreated, it may cause additional difficulties in the body. Certain types of STIs can cause sterility or even death. Some common STDs are chlamydia, gonorrhea, trichomoniasis, syphilis, herpes, and HPV (genital warts). From time to time STDs are called "VD". You can get an STD if you have sex (ANY kind of sex - vaginal, anal or oral) lacking of a condom with someone who has an STD.

HIV is the virus that reasons AIDS (Acquired Immune Deficiency Syndrome). HIV is spread by having vaginal, anal or oral sex without a condom with somebody who has HIV. You can too acquire HIV if you share drug "works" (such as needles and syringes) with somebody who has HIV. HIV attacks the body's immune structure and makes it feeble. An individual with HIV has AIDS when his/her body's immune system develops too weak to fight diseases. There are medicines that can support persons with HIV, nonetheless there is no cure for HIV or AIDS.

Track 3: HIV/AIDS, STDs & STIs

AIDS views for Acquired Immunodeficiency Syndrome. It is the outcome of HIV attacking the human immune structure to the point where the body cannot combat off numerous diseases and infections (termed opportunistic infections) that characteristically don’t disturb a person with a healthy immune system. AIDS is the utmost radical stage of HIV and can only be identified by a doctor. HIV is spread when an HIV-infected individual's body fluids (blood, semen, fluids from the vagina or breast milk) arrive alternative person’s bloodstream. The greatest mutual way persons are infected with HIV is by having unprotected sex (vaginal, anal or oral). While having unprotected sex, the virus can enter the bloodstream through linings in the mouth, anus, sex organs (the penis and vagina), or over cracked skin. Pregnant women with HIV can give the virus to their babies during pregnancy, child birth or over breast feeding. HIV can as well be spread by sharing needles that are used for taking drugs (legal and illegal), tattooing, and piercing. Together men and women can spread HIV. An individual with HIV can feel okay and still spread the virus to others.

Track 4: Epidemiology of HIV/AIDS, STDs & STIs

The Centers for Disease Control and Prevention (CDC) in Atlanta evaluate that about 12 million U.S. citizens develop an STD each year, and that at least 50 percent of all persons in the U.S. will develop an STD at certain time beforehand they are 35 years old. The STD that an individual is likely to develop has to do by anywhere they aware as well as with whom they engage in dangerous sexual activities. It likewise has to do with the physiognomies of the organism causing the STD. Numerous factors contribute to the growth and maintenance of STDs all over the world - not just separate sexual behaviour. There are countless reasons why positive organisms are focused in certain geographic regions, and why definite sub- populations are at higher danger of receiving an STD than others. Rural-to-urban relocation, insufficiency, war, and lack of access to medical precaution or medicines are motives why sicknesses blast within certain populations. Whereas these subjects exist worldwide, often they are further intense in tropical developing countries where there are fewer resources. There are types of specimens used clinical pathology. They are blood, urine, sputum, faeces, and other body fluids, in which it deals with health care, particularly the analysis and management of disorders affecting the female reproductive system. Asia-Pacific and some countries in Rest of the World region are predictable to show lucrative evolution in future period, owing to rapidly growing occurrence and consciousness about the diseases caused due to gram-positive bacteria and their chronic properties. The worth of microbials and microbial physiology microbials market is expected to increase to $4,456.37 million by 2019 at a CAGR of 15.3% from 2014. The market is estimated to show a prominent development during the estimate period 2014 – 2020.

Track 5: STD symptoms: Common STDs and their symptoms

Sexually transmitted diseases (STDs) are contagions that you can acquire from having sex with somebody who has the infection. The reasons of STDs are bacteria, parasites and viruses. There are further than 20 sorts of STDs, counting Chlamydia, Gonorrhea, Genital herpes, HIV/AIDS, HPV, Syphilis, and Trichomoniasis. Maximum STDs disturb together men and women, but in numerous cases the health complications they cause can be additional severe for women. If a pregnant woman has an STD, it can cause severe healthiness difficulties for the baby. If STD caused by bacteria or parasites, health care provider can treat it with antibiotics or added medicines. If STD initiated by a virus, there is no cure. At times medicines can keep the disease under control. Accurate usage of latex condoms importantly decreases, but does not totally remove, the danger of catching or spreading STDs.

Track 6: HIV/AIDS, STDs & STIs - testing

Several STIs have no signs or indications in the majority of persons diseased. Or they have slight signs that can be simply ignored. This is why the term “disease” (as in STD) is starting to be changed by infection (or STI). STDs may be noticed throughout a physical exam; through Pap smears; and in examinations of blood, urine, and genital and anal secretions.

Sexually active men and women might be at danger for sexually transmitted diseases (STDs). The threat of narrowing an STD is in a straight line linked to the number of sexual partners the individual or his/her mate(s) have had. It is estimated that more than 20 percent of persons with added than one sexual mate have an STD. Threat is tremendously little for a couple that has only had intimate contact (genital/genital, oral/genital, anal/genital, finger/vaginal/anal) with each other and has not ever had any form of intimate sexual interaction with others. Consistent condom use suggestively decreases the danger of contact to many sexually transmitted infections.

Track 7: Prevention of Mother-to-Child Transmission

Mother-to-child transmission of HIV is the spread of HIV from an HIV-infected woman to her juvenile through pregnancy, delivery, or breastfeeding. Mother-to-child transmission is the maximum common method that offspring turn out to be diseased with HIV. Pregnant women with HIV obtain HIV drugs throughout pregnancy and delivery to decrease the danger of mother-to-child transmission of HIV. In some circumstances, a woman with HIV may have an arranged cesarean delivery (sometimes called a C-section) to stop mother-to-child transmission of HIV during delivery. Babies born to women with HIV obtain HIV medicine for 6 weeks after birth. The HIV medicine decreases the risk of infection from any HIV that may have entered a baby’s body in the course of childbirth. Because HIV can be transmitted in breast milk, women with HIV living in the United States should not breastfeed their babies. In the United States, baby formula is a safe and healthy alternative to breast milk.

Track 8: STDs & Infertility

Chlamydia and gonorrhea are important avoidable reasons of pelvic inflammatory disease (PID) and infertility. Untreated, around 10-15% of women with chlamydia will improve PID. Chlamydia can similarly cause fallopian tube contamination without any indications. PID and “silent” infection in the higher genital tract could cause everlasting injury to the fallopian tubes, uterus, and surrounding tissues, which can lead to sterility.
An estimated 2.86 million cases of chlamydia and 820,000 cases of gonorrhea happen yearly in the United States. Maximum women diseased with chlamydia or gonorrhea have no indications.

CDC acclaims yearly chlamydia and gonorrhea screening of completely sexually active women younger than 25 years, as well as older women with risk factors such as new or multiple sex partners, or a sex mate who has a sexually transmitted infection.

Track 9: Treatment for Sexually Transmitted Infections

Bacterial STDs can be treated with antibiotics if treatment begins prompt enough. Viral STDs cannot be cured, but indications can be managed with medicines. There is a vaccine counter to hepatitis B, but it will not help if previously have the disease. STIs initiated by bacteria are usually easier to treat. Viral infections can be managed but not continuously cured. If you're pregnant and have an STI, quick action can stop or reduce the threat of infection of the baby. The treatment of STDs depends on the infection. In the case of gonorrhea and chlamydia, generally give an antibiotic injection to treat gonorrhea and oral antibiotics to treat chlamydia.

Track 10: Diagnosis of STDS

Certain STDs can be identified without any examinations at all (pubic lice). Other STDs need a blood assessment or a sample of any uncommon fluid such as an abnormal discharge from the vagina or the penis for gonorrhea or chlamydia to be analyzed in a lab to help found a analysis. Certain trials are finished even though a person waits; other assessments need a few days earlier a person may get the results. Physical examination, and thorough medical history, plus one or more of the following blood tests in individuals 18 months of age or greater: Quick HIV test completed on blood or saliva, ELISA (Enzyme-Linked Immunosorbent Assay) antibody blood examination. If the sample tests positive for HIV, the more-accurate Western blot antibody blood test or an HIV nucleic acid trial (viral load or HIV DNA PCR) is performed to confirm a diagnosis. For infants under 18 months of age, an HIV nucleic acid test is suggested.

Track 11: Advanced Techniques involved in STDs

Light microscopic inspection of a trial of urethral discharge can be used to diagnose gonorrhea in men. Nucleic acid amplification tests (NAATs) might also be used. In male gonorrheal urethritis, stained microscope slides will display Gram-negative diplococci. For women, an additional sensitive and unambiguous test is needed, and NAATs of urine or of a swab of the affected area are the chosen test methods.

Urine samples can be used to exam for urethritis in both sexes. Current urination will have washed gonorrheal discharge from the urethra. Consequently, to collect adequate release, urine trials must be taken at least an hour after the patient’s last urination.

Vaginal swab samples are used to test for cervicitis. Gonorrheal cervicitis produces adequate discharge that swabs need not be taken by speculum inspection. In its place, they can be collected dimly by the patient herself.

Aimed at oral or anal gonorrhea, pharyngeal or rectal swabs are taken and sent to the lab for culturing. N. gonorrhoeae is a comparatively fragile organism, so all swab models must be put in the suitable media, transported to the lab quickly, and not ever refrigerated. For the Diagnosis of pathogenic microorganisms, the direct examination and techniques contains Immunofluorescence, immuno-peroxidase staining, and other immunoassays might detect specific microbial antigens. In molecular medicine generally Genetic probes identify genus- or species-specific DNA or RNA sequences.

Track 12: Vaccine Development for STDS:

The reliable use of condoms will decrease the danger of contracting and spreading HPV infections. The HPV2 and HPV4 vaccines are suggested for the immunization of together males and females.

The Advisory Committee on Immunization Practices (ACIP) indorses either vaccine for repetitive use in women ages 11 or 12 years. Preferably, the vaccination must be given earlier a girl or woman has developed sexually active because it does not guard against existing HPV infections. The current HPV vaccine does not safeguard against all possibly cancer-causing types of HPV. Therefore, all women—even those who have been vaccinated against HPV—should have regular Pap tests.

The CDC endorses the HPV vaccine for all males ages 11 to 12 and those to age 21 who have not had all three doses of the vaccine. It is also suggested for gay, bisexual, and men who have sex with men. Men through age 26 who are immunocompromised, counting HIV positive, who have not had all three doses might also profit. The vaccine is utmost effective when given to younger males. The vaccine has been proven to prevent genital warts and anal cancers in males and may help to stop cancers of the oropharynx and penis (ACIP, 2014).

Moreover, HPV vaccination can be paid for by the U.S. Vaccines for Children Program. This federal program protections the cost of optional vaccinations for children through the age of 18 years if they are Medicaid-eligible, uninsured, underinsured for vaccinations, Native American, or Alaskan Native.

Track 13: Outbreaks- HIV/AIDS, STDs & STIs

The percentage of attainment of viral STDs is growing, and utmost viral infections cannot be treated by medicines. Data from the World Health Organization (WHO, 2015b) estimate a worldwide figure of roughly 35 million people who are living with the human immunodeficiency virus (HIV). The same data show approximately 1,370,000 deaths by acquired immune deficiency syndrome (AIDS) universal in the countries reporting data (notably, the United States and China are not involved in the reported data), but the disease development in HIV/AIDS can be reduced by antiretroviral medications, and the regularity of outbreaks can be reduced by antiviral medicines, as in the case of herpes simplex virus (HSV). Throughout the primary infection, and occasionally during recurrent outbreaks, herpes simplex virus can cause cervicitis that contains vesicles and ulcers. There is usually no mucopurulent exudate with herpes cervicitis.

Track 14: Immunology of HIV/AIDS, STDs & STIs

Adults with immunodeficiencies are abundant extra likely to suffer from molluscum contagiosum. Around 90% of patients who are HIV-positive have skin lesions of certain sort, counting molluscum contagiosum. In one revision, 18% of patients who were HIV positive were found to have molluscum contagiosum. In immunodeficient people, molluscum contagiosum can spread to all body surfaces. Immunocompetent adults do not get molluscum contagiosum lesions far from the genital area. The appearance of molluscum contagiosum on the face of an adult is a good indicator that they have an HIV infection or some other immunosuppressive condition. Immunogenetics helps in thoughtful the pathogenesis of several autoimmune and infectious diseases and bacterial infections under clinical studies of STDs.

The Public Health Service (PHS) is committed to achieving the health promotion

and disease prevention objectives of "Healthy People 2000," a PHS-led national

activity for setting priority areas. This Program Announcement (PA), Research

on Molecular Immunology of STDs, is related to the priority area of sexually

transmitted diseases.

Track 15: Public Awareness on STDS

Sexually transmitted Infections (STIs) rank amongst the greatest significant health problems for the people particularly the young adults global. Young people tend to participate in sexual activity at younger ages in the past period than in the 1970s, and 1980s. Information is an indispensable forerunner of sexual risk reduction.

The Sexually Transmitted Disease (STD) infection prevention and control platform works to decrease the occurrence of sexually transmitted diseases. Through providing screening, testing, diagnosis and treatment for infected persons, the STD program is fighting the war in contradiction of sexually transmitted diseases one individual at a time. Categorizing and providing prophylactic action and therapy for sexual partners of confirmed cases is additional task of the STD program. These roles coupled with increasing the level of public consciousness to sexually transmitted diseases describe the role of the STD program within the Miami-Dade County Health Department (MDCHD). The program's interference helps to defend diseased persons, their partners and unborn offspring from the serious problems that may result from untreated STDs. Four major program components comprise the STD Prevention and Control Program. They are: Surveillance, Field Services including Partner Counselling and Referral Services, Clinical Services containing Locations and Hours, Community Relations and Information for Teens.

Track 16: Entreprenuers Investment Summit

Enterpreneurs from any field can exhibit their products and can give a presentation on their products which should be helpful in business development and marketing.

ConferenceSeries Ltd invites all the participants from all over the world to attend 5^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs which is going to be held in London, UK during June 19-20, 2017

Sexually transmitted diseases (STDs) are infections that can be seen when anyone having sex with someone who has the infection. The causes of STDs are bacteria, parasites and viruses, protozoans. There are more than 20 types of STDs. STDs affect both men and women, but in many cases the health problems and their cause can be seen more severe in women. If a pregnant woman has an STD, it can cause serious health problems for the baby. If you have an STD caused by bacteria or parasites, your health care provider can treat it with antibiotics or other medicines. If you have an STD caused by a virus, there is no cure. Sometimes medicines can keep the disease under control. Correct usage of latex condoms greatly reduces, but does not completely eliminate, the risk of catching or spreading STDs.

For Sexually transmitted diseases prevention is better than cure.

The conference on 5^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs which is going to be held in London, UK during June 19-20, 2017 will be helpful to lay a new platform for all the scientists and health care professionals to invent new preventive and control measures for the treatment of STDS.

For abstract submission please go through the link: http://std.conferenceseries.com/call-for-abstracts.php

For Registration please go through the link: http://std.conferenceseries.com/registration.php

Market Analysis Report:

According to the World Health Organization (WHO, 2015a), 498 million people ages 15 to 49 are infected every year with chlamydia, gonorrhea, syphilis, or trichomoniasis. It has also been estimated that 106 million people worldwide are infected specifically with gonorrhea each year. Gonorrhea infections can be cured by antibiotics, but untreated infections can lead to pelvic inflammatory disease (PID), ectopic pregnancies, premature deliveries, and infertility, all of which are more common in the developing world. Study results show that gonorrhea’s ability to develop resistance to treatment, such as extended-range cephalosporins, raises concern that the infection could become untreatable (Blomquist et al., 2014).

The rate of acquisition of viral STDs is increasing, and most viral infections cannot be cured by medicines. Data from the World Health Organization (WHO, 2015b) estimate a global figure of approximately 35 million people who are living with the human immunodeficiency virus (HIV). The same data show approximately 1,370,000 deaths by acquired immune deficiency syndrome (AIDS) worldwide in the countries reporting data (notably, the United States and China are not included in the reported data) (WHO, 2015b). But the disease progression in HIV/AIDS can be slowed by antiretroviral drugs (Bichoupan & Dieterich, 2014), and the frequency of outbreaks can be decreased by antiviral drugs, as in the case of herpes simplex virus (HSV).

Some STDs last a long time, and some STDs are incurable; therefore, the prevalence of STDs is much higher than their incidence. With over 19.7 million newly occurring STDs annually in the United States, rates of new STD infections are among the highest in the developed world. This is compared to 498 million newly occurring, curable STDs every year (Blomquist et al., 2014).

The cost is $15.6 billion/year for the eight most common newly diagnosed STDs in the United States. Part of this cost includes infection prevention efforts that address abstention, reducing the number of sexual partners, using condoms, and effective vaccines. Testing and prompt treatment are also part of the cost and can reduce expenses by preventing long-term effects. The greatest cost involves life-long treatment for certain STDs such as HIV and HPV-related cancers (CDC, 2013a).

Major Sexually Transmitted Diseases Associations Around the Globe:

European Society of Clinical Microbiology and Infectious Diseases

International Union of Microbiological Societies

Society for general Microbiology

Federation of Infection Societies

Canadian Society of Microbiologists

British Infection Association

Federation of European Microbiological Societies

Welsh Microbiology Association

Clinical Virology Network

Infectious Diseases Society of America

American Society for Microbiology

Top Universities Associated With STD’s:

Figure 1: Top Universities Associated With STD’s
Source: Reference: 8

Top Universities in Europe:

Figure 2: Top Universities in Europe

Target Audience:

Industry 63%

Academia 30%

Others 7%

Figure3: Target Audience

Source: Reference 3

Companies Associated with STD’s

Figure 4: Companies Associated with STD's

Source: Reference 4

Statistical Analysis of Associations:

Figure 5: Statistical Analysis of Associations
Source: Reference 6

Percentage of Revenue Contribution for Research on STD’S:

Figure 6: Percentage of Revenue Contribution for Research on STD’S

Top global pharmaceutical companies manufacturing antimicrobial products:

1) Pfizer

2) Merck and Co

3) Johnson and Johnson

4) GlaxoSmithKline

5) Bristol-Meyers Squibb

6) Aventis

7) Pharmacia

8) Novartis

9) F. Hoffmann-La Roche

10) Astra Zeneca

11) Abott Laboratories

12) Wyeth

13) Eli Lilly and Co

14) Schering Plough

15) Bayer

Source: Reference 6

Funding sources and prevention of infectious diseases in Europe for STD's research:

Many U.K agencies are working to improve the health of world’s population. Under the Global Health Initiative (GHI), there is a concerted effort to improve coordination across U.S. agencies to increase efficiencies and align investments with recipient country priorities, with the aim of making programs sustainable. Some of the major funding agencies include:

1) Centres for disease control and prevention

2) NIH

3) The global fund to fight AIDS, TB and Malaria.

4) UNAIDS

5) ASM

6) AAAS

7) ASTMH

8) IDSA etc.

Source: Reference 8

References:

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 19-20, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View

5^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs June 19-20, 2017 London, UK

Recommended Global Infectious Diseases Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

STD-HIV/AIDS 2017

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues